Company Filing History:
1 out of 54 
1 out of 43 Years Active: 2017
Title: The Innovative Contributions of Naohira Kanayama
Introduction
Naohira Kanayama, a distinguished inventor based in Higashi-ku, Japan, has made significant strides in the field of medical research. His work focuses on advancing treatments for conditions such as cancer through innovative methodologies and compositions.
Latest Patents
Kanayama holds a patent for "Methods and compositions related to annexin 1-binding compounds." This patent discloses a range of conjugates that include the annexin 1-binding peptide IFLLWQR, which is covalently linked to therapeutic or detectable agents. Additionally, it outlines compositions that contain a moiety alongside a peptide that can bind to carbohydrate receptors on cells. His inventive work further encompasses isolated nucleic acids containing sequences encoding peptides that also bind to these carbohydrate receptors. Methods of targeting tumor cells by administering compositions containing these peptides are also integral to his inventions, showcasing their potential use in cancer treatment.
Career Highlights
Throughout his career, Naohira Kanayama has been associated with reputable research institutions, including the Burnham Institute for Medical Research and Hamamatsu University School of Medicine. His tenure at these institutions has allowed him to develop his expertise and contribute to advancements in medical research and innovation.
Collaborations
Collaboration plays a pivotal role in Kanayama's work, allowing him to partner with esteemed colleagues such as Michiko N. Fukuda and Kazuhiro Sugihara. These associations have facilitated the exchange of ideas and have enhanced the development of innovative methodologies in cancer treatment and medical research.
Conclusion
Naohira Kanayama stands out as a noteworthy inventor whose contributions to the field of medical innovations demonstrate a commitment to improving treatment methodologies. His patent, which includes a comprehensive approach to targeting tumor cells, not only highlights his inventive spirit but also underscores the importance of collaboration in scientific advancements. As the scientific community continues to evolve, the work of innovators like Kanayama remains essential in the fight against diseases such as cancer.